Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes

Published:2019-05-21 Issue:5 Volume:25 Page:867-875
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Warren Beth Boulden¹^ORCID,Jacobson Linda¹,Kempton Christine²^ORCID,Buchanan George R.³,Recht Michael⁴⁵,Brown Deborah⁶,Leissinger Cindy⁷,Shapiro Amy D.⁸,Abshire Thomas C.²⁹,Manco‐Johnson Marilyn J.¹^ORCID,Riske Brenda,Hacker Michele R.,Kilcoyne Ray,Ingram J. David,Manco‐Johnson Michael L.,Funk Sharon,Valentino Leonard A.,Hoots W Keith,DiMichele Donna,Bleak Shirley,Cohen Alan,Mathew Prasad,Matsunaga Alison,Medeiros Desiree,Nugent Diane,Thomas Gregory A.,Thompson Alexis A.,McRedmond Kevin,Soucie J. Michael,Austin Harlan,Evatt Bruce L.,

Affiliation:

1. University of Colorado Anschutz Medical Campus Aurora Colorado

2. Emory University School of Medicine Atlanta Georgia

3. Children's Medical Center at Dallas University of Texas Southwestern Medical Center Dallas Texas

4. Phoenix Children's Hospital Phoenix Arizona

5. Oregon Health & Science University Portland Oregon

6. University of Texas Houston Texas

7. Tulane University New Orleans Louisiana

8. Indiana Hemophilia and Thrombosis Center Indianapolis Indiana

9. Blood Research Institute BloodCenter of Wisconsin/Versiti Milwaukee Wisconsin

Funder

Centers for Disease Control and Prevention

Bayer Schering

Hemostasis and Thrombosis Research Society

Maternal and Child Health Bureau

NIH Clinical Center

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13778

Reference37 articles.

1. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

2. HemophiliaN.Foundation Medical and Scientific Advisory Council (MASAC). MASAC recommendation concerning prophylaxis. NHF MASAC Guidelines. 2016.

3. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A

4. Consensus perspectives on prophylactic therapy for haemophilia: summary statement

5. The Impact of Prothrombotic Mutations on Factor Consumption in Adult Patients with Severe Hemophilia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor;Journal of Thrombosis and Haemostasis;2023-05

2. Long-term prophylaxis: what are our options and how to define success?;Hematology;2022-12-09

3. Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting;Research and Practice in Thrombosis and Haemostasis;2021-07

4. Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers;Journal of Blood Medicine;2021-04

5. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary;Haemophilia;2020-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3